Fear is a great business model
As new variants of the SARS-CoV-2 virus continue to spread around the world, vaccines produced by Moderna, BioNTech/Pfizer, and Johnson & Johnson won’t be enough to provide immunity forever, says Stéphane Bancel. Speaking at the Forbes Health In Action Summit, the Moderna CEO says it’s likely booster shots will be needed in the near future, both to bolster waning immunity and to protect against new virus mutations.
“First, immunity wanes with time meaning rollover of antibodies you have in your body from the vaccine - all natural infection goes down over time,” he says. “Two is you don’t know which virus you’re going to get infected with down the road, which variant is one of the four areas alpha, beta, gamma, delta, or even a new one that we don’t know of yet. And then it depends on your age and medical condition.”